{"news": [{"date": "20240224065816", "headline": "Danaher Full Year 2023 Earnings: Misses Expectations", "summary": "Danaher ( NYSE:DHR ) Full Year 2023 Results Key Financial Results Revenue: US$23.9b (down 10% from FY 2022). Net..."}, {"date": "20240225002750", "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of February 25", "summary": "Stay updated on dividend activity for Dividend Champions, Contenders, and Challengers."}, {"date": "20240225133811", "headline": "Bill Gates\u2019 16 Dividend Stocks To Buy", "summary": "In this article, we will take a detailed look at Bill Gates\u2019 16 Dividend Stocks To Buy. For a quick overview of such stocks, read our article Bill Gates\u2019 5 Dividend Stocks To Buy. The era of low interest rates did not bode well for dividend investing as investors preferred to pile into growth stocks instead of [\u2026]"}, {"date": "20240226003600", "headline": "RBC Capital Remains a Hold on B&G Foods (BGS)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240226113722", "headline": "NetScout Systems: Long-Term Issues Remain A Concern", "summary": ""}, {"date": "20240226191700", "headline": "Danaher's Spun-Off Company Veralto Is \"Next High-Quality Serial Compounder\" - Analyst", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240226202800", "headline": "Barclays Releases a Hold Rating on B&G Foods (BGS)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240226212800", "headline": "B&G Foods Holdings: New Investment Opportunity Emerges", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240227053600", "headline": "Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240227064900", "headline": "Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2023 Update", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240227103600", "headline": "Danaher Corp. stock rises Tuesday, outperforms market", "summary": "Shares of Danaher Corp. rallied 1.28% to $254.86 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500..."}, {"date": "20240227151500", "headline": "Danaher to Present at TD Cowen Health Care Conference", "summary": "Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m. ET. The event will be simultaneously webcast on www.danaher.com."}, {"date": "20240227165432", "headline": "Tracking George Soros's 13F Portfolio - Q4 2023 Update", "summary": "Soros Fund Management's portfolio value grew in Q4 2023 with top holdings in Splunk, AerCap, and Alphabet. Explore more here."}, {"date": "20240227213600", "headline": "B&G Foods Sell Rating: Overly Optimistic Projections Amidst Intense Market Competition", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240228031100", "headline": "Beyond Market Price: Uncovering Danaher Corp's Intrinsic Value", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240228160009", "headline": "Tracking Al Gore's Generation Investment Management Portfolio - Q4 2023 Update", "summary": ""}, {"date": "20240228170006", "headline": "Why the Market Dipped But Danaher (DHR) Gained Today", "summary": "Danaher (DHR) reachead $255.71 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close."}, {"date": "20240229053000", "headline": "FPA Queens Road Value Fund Q4 2023 Commentary", "summary": "FPA Queens Road Value Fund (\u00e2\u0080\u009cFund\u00e2\u0080\u009d) returned 11.75% for the fourth quarter of 2023. Click here to read the full fund letter."}, {"date": "20240229103040", "headline": "Why Is Danaher (DHR) Up 6.6% Since Last Earnings Report?", "summary": "Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues."}, {"date": "20240229180100", "headline": "How Larry Culp Saved GE by Breaking It Up", "summary": "General Electric will soon be no more, but shares of the three new companies look attractive."}, {"date": "20240301080012", "headline": "Is Trending Stock Danaher Corporation (DHR) a Buy Now?", "summary": "Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects."}, {"date": "20240302094246", "headline": "16 Best Large-Cap Value Stocks To Invest In in 2024", "summary": "In this piece, we will take a look at the 16 best large cap value stocks to invest in in 2024. If you want to skip our overview of the latest stock market news, then you can skip ahead to 5 Best Large-Cap Value Stocks To Invest In in 2024. The stock market of 2024 [\u2026]"}, {"date": "20240304103600", "headline": "Danaher Corp. stock rises Monday, outperforms market", "summary": "Shares of Danaher Corp. inched 0.13% higher to $256.19 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..."}, {"date": "20240304200600", "headline": "Wells Fargo\u2019s Core List of industry Leaders to withstand the test of time", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240305091502", "headline": "Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference (Transcript)", "summary": "Danaher Corporation (NYSE:NYSE:DHR) TD Cowen 44th Annual Health Care Conference March 5, 2024 11:10 AM ETCompany ParticipantsRainer Blair - President,..."}, {"date": "20240305103600", "headline": "Danaher Corp. stock outperforms market despite losses on the day", "summary": "Shares of Danaher Corp. slid 0.70% to $254.39 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..."}, {"date": "20240305164345", "headline": "Tracking Dan Loeb's Third Point Portfolio - Q4 2023 Update", "summary": ""}, {"date": "20240305170011", "headline": "Danaher (DHR) Stock Moves -0.7%: What You Should Know", "summary": "Danaher (DHR) reachead $254.39 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close."}, {"date": "20240305230100", "headline": "Invest with Confidence: Intrinsic Value Unveiled of Danaher Corp", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240306214100", "headline": "Danaher Corp. stock rises Thursday, still underperforms market", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240307220800", "headline": "Discovery Harbour Welcomes New Interim CEO", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240309023548", "headline": "GE HealthCare Technologies' Roar Higher Isn't Over Yet", "summary": "GE HealthCare Technologies is expected to see profits and cash flows rise in 2024, leading to a potential strong upside for the stock. Read more here."}, {"date": "20240311010000", "headline": "Cepheid Receives FDA Clearance for Xpert\u00ae Xpress GBS", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240311161521", "headline": "Why Danaher (DHR) Dipped More Than Broader Market Today", "summary": "Danaher (DHR) closed the most recent trading day at $252.80, moving -0.35% from the previous trading session."}, {"date": "20240312160019", "headline": "Danaher (DHR) Gains But Lags Market: What You Should Know", "summary": "Danaher (DHR) reachead $253.10 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close."}, {"date": "20240312214200", "headline": "Danaher Corp. stock rises Wednesday, outperforms market", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240313053545", "headline": "LGI: Unique Equity CEF With Fully-Covered Distribution At An Enormous Discount", "summary": ""}, {"date": "20240313053800", "headline": "Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240313082300", "headline": "Danaher (DHR) Benefits From Business Strength Amid Risks", "summary": "Danaher (DHR) gains from strength in academic and life science research markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology and Diagnostics units is concerning."}, {"date": "20240314203600", "headline": "Danaher's Options Frenzy: What You Need to Know", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240315024000", "headline": "China stimulus positive for GE HealthCare, tool companies, says Evercore ISI", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240318004625", "headline": "More Big Changes To My Dividend Growth Portfolio", "summary": "I have been actively reshaping my portfolio by selling off low-conviction holdings and focusing on high-growth compounders. Explore more details here."}, {"date": "20240318161517", "headline": "Why Danaher (DHR) Outpaced the Stock Market Today", "summary": "The latest trading day saw Danaher (DHR) settling at $251.47, representing a +0.83% change from its previous close."}, {"date": "20240319051700", "headline": "IP\u2019s stock jumps after replacing longtime CEO with an investment-firm veteran", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240319065800", "headline": "International Paper\u2019s stock jumps after replacing longtime CEO with an investment-firm veteran", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240319223340", "headline": "Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader", "summary": "Cytek Biosciences is thriving in a challenging healthcare market, driven by its advanced technology and promising growth opportunities. Read more on CTKB here."}, {"date": "20240320160018", "headline": "Danaher (DHR) Stock Declines While Market Improves: Some Information for Investors", "summary": "The latest trading day saw Danaher (DHR) settling at $251.68, representing a -0.81% change from its previous close."}, {"date": "20240321052734", "headline": "Revvity: Enter Now As Reorganization Takes Shape", "summary": "Revvity has historically underperformed its peers and aims to drive differentiation through inorganic investments. Check out why RVTY stock is a strong buy."}, {"date": "20240321062707", "headline": "20 Upcoming Dividend Increases To Finish Q1", "summary": "Companies who regularly raise their dividends perform better, 20 have increased 8.5% on average. Explore more for a list of top stocks expected to raise dividends."}, {"date": "20240321070011", "headline": "Here is What to Know Beyond Why Danaher Corporation (DHR) is a Trending Stock", "summary": "Zacks.com users have recently been watching Danaher (DHR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects."}, {"date": "20240321082503", "headline": "11 Best Healthcare ETFs To Buy Now", "summary": "In this article, we discuss 11 best healthcare ETFs to buy now. If you want to skip our discussion on the healthcare industry, head over to 5 Best Healthcare ETFs To Buy Now. In 2023, the healthcare sector faced challenges as investors adjusted portfolios in anticipation of higher interest rates. Although the sector lagged behind [\u2026]"}, {"date": "20240321141500", "headline": "Danaher Schedules First Quarter 2024 Earnings Conference Call", "summary": "Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations."}, {"date": "20240321214200", "headline": "Danaher Corp. stock rises Friday, outperforms market", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240324023716", "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of March 24", "summary": "Stay updated with weekly dividend activities, changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers. Read more here."}, {"date": "20240324190600", "headline": "Ingersoll-Rand's Dover deal not a threat to bioprocessing space, says KeyBanc", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240324214100", "headline": "Danaher Corp. stock falls Monday, underperforms market", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240324222033", "headline": "GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive", "summary": "GE Healthcare Technologies has good near-term and long-term revenue growth prospects. Click here to see why GEHC stock is a Buy."}, {"date": "20240325202100", "headline": "Looking Into Danaher's Recent Short Interest", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240326161519", "headline": "Danaher (DHR) Gains As Market Dips: What You Should Know", "summary": "Danaher (DHR) reachead $248.46 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close."}, {"date": "20240326183141", "headline": "Danaher: All In On Life Sciences, And Market Update", "summary": "Danaher Corporation's full focus on healthcare will reduce cyclicality and increase profitability. Click here to read why DHR stock is a Buy."}, {"date": "20240326203600", "headline": "Danaher put volume heavy and directionally bearish", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240327060000", "headline": "Invest Like Bill Gates With These 3 AI Stocks to Buy", "summary": "Bill Gates\u2019 old company, Microsoft (NASDAQ:MSFT), would undoubtedly be on his list of AI stocks to buy. I suspect it\u2019s on most AI investors\u2019 must-own list. At the end of December, the Bill & Melinda Gates Foundation Trust had invested $42.3 billion in U.S.-listed stocks, according to the foundation\u2019s 13F. Those assets were invested in 24 stocks, with Microsoft accounting for one-third of the portfolio\u2019s assets. That means the average market value of the remaining 23 stocks was approximately $1.2"}, {"date": "20240327073011", "headline": "Wall Street Analysts See Danaher (DHR) as a Buy: Should You Invest?", "summary": "According to the average brokerage recommendation (ABR), one should invest in Danaher (DHR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?"}, {"date": "20240327160021", "headline": "Danaher (DHR) Rises Yet Lags Behind Market: Some Facts Worth Knowing", "summary": "Danaher (DHR) reachead $248.77 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close."}, {"date": "20240328063900", "headline": "10 Health Care Stocks With Whale Alerts In Today's Session", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240331212200", "headline": "Danaher files automatic mixed securities shelf", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240331212600", "headline": "Danaher files for mixed shelf offering", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240331224100", "headline": "Market Today: Mixed Market Movements Amid Sector Shifts and Corporate Developments", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240402161518", "headline": "Danaher (DHR) Suffers a Larger Drop Than the General Market: Key Insights", "summary": "In the closing of the recent trading day, Danaher (DHR) stood at $245.94, denoting a -0.75% change from the preceding trading day."}, {"date": "20240403010000", "headline": "Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240403212100", "headline": "Unpacking the Latest Options Trading Trends in Danaher", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404024307", "headline": "Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence", "summary": "Bio-Techne in the life science tools sector holds strong financials. With high profit margins and low leverage, it is a top performer among its peers. Explore more here."}, {"date": "20240404034000", "headline": "Interesting DHR Put And Call Options For May 24th", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404070011", "headline": "Investors Heavily Search Danaher Corporation (DHR): Here is What You Need to Know", "summary": "Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects."}, {"date": "20240405054711", "headline": "BME: Trading At A Historical Discount To NAV", "summary": "BlackRock Health Sciences Trust offers 6.35% dividend yield & discounted NAV, providing an opportunity to benefit from healthcare sector growth. Learn more on BME CEF here."}, {"date": "20240405160021", "headline": "Here's Why Danaher (DHR) Gained But Lagged the Market Today", "summary": "In the closing of the recent trading day, Danaher (DHR) stood at $244.28, denoting a +0.98% change from the preceding trading day."}, {"date": "20240408013100", "headline": "Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240408230241", "headline": "Veralto: A Solid Start Since The Spin-Off", "summary": "Veralto has seen its shares trade in a $65-$90 range since the fall. Read more to see my recommendation on VLTO stock."}, {"date": "20240409010000", "headline": "The Ultimate 5: Unveiling My All-Time Favorite Dividend Growth Investments", "summary": "Read here to know about the influential work of psychologist Daniel Kahneman and its impact on human decision-making in finance and beyond."}, {"date": "20240409042500", "headline": "Oakmark Global Fund: First Calendar Quarter 2024 Commentary", "summary": "The Oakmark Global Fund generated a 4.35% return in the first quarter, compared to an 8.88% return for the MSCI World Index."}, {"date": "20240409194700", "headline": "Danaher (DHR) Receives a Hold from Barclays", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240409202000", "headline": "Oakmark Global Select Fund: First Calendar Quarter 2024", "summary": "The Oakmark Global Select Fund returned 2.95% for the quarter, underperforming the MSCI World Index, which returned 8.88%."}, {"date": "20240409224600", "headline": "Danaher price target raised by $20 at Barclays, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240410024600", "headline": "RBC Capital Keeps Their Hold Rating on B&G Foods (BGS)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240410064959", "headline": "908 Devices: Rare Early-Stage Bioprocess Investment Opportunity", "summary": "908 Devices is a promising company producing mass spectrometry and bioprocess analysis tools, and shows a profitable future. Learn why I rate MASS stock a buy."}, {"date": "20240411040500", "headline": "Interesting DHR Put And Call Options For May 31st", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240411143000", "headline": "Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024", "summary": "Healthcare\u2019s impact on the economy cannot be overstated. According to the American Medical Association, the U.S. spends more than $4 trillion a year on healthcare, which works out to nearly $13,000 per person. That makes America one of the top spenders on per capita healthcare in the world. And healthcare spending shows no signs of slowing down with the population aging and the Baby Boom generation now firmly among the ranks of senior citizens. The stock market is full of healthcare securities."}, {"date": "20240412010000", "headline": "Here It Is! My 20-Stock 6-Figure Market-Beating Dividend Portfolio", "summary": "In this article, I share my 20-stock dividend growth portfolio, which I haven't done for more than a year. Explore more details here."}, {"date": "20240412063600", "headline": "This Is What Whales Are Betting On Danaher", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240412103000", "headline": "Reasons Why Danaher (DHR) Should be in Your Portfolio Now", "summary": "Danaher (DHR) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies."}, {"date": "20240413001000", "headline": "Ensemble Capital Management Q1 2024 Letter", "summary": "After outperforming the market handily in the previous quarter, our strategy produced returns in line with the S&P 500 this quarter. Click here to read more."}, {"date": "20240415231900", "headline": "HSBC gets more bullish on Danaher, upgrades shares", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240416102442", "headline": "FHLC: Healthcare Dashboard For April", "summary": "Fidelity MSCI\u00c2\u00a0Health Care\u00c2\u00a0Index ETF is an alternative to XLV for long-term investors. Read this article to learn more about FHLC ETF."}, {"date": "20240416213300", "headline": "AdaptHealth names Suzanne Foster as CEO", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240416235100", "headline": "HSBC upgrades Danaher to Buy on biotech funding recovery", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417000100", "headline": "The Art of Valuation: Discovering Danaher Corp's Intrinsic Value", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417024100", "headline": "Unusually active option classes on open April 17th", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417024400", "headline": "Amazon, Apple initiated: Wall Street's top analyst calls", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417050300", "headline": "Forecasting The Future: 7 Analyst Projections For Danaher", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417124739", "headline": "HSBC Upgrades Danaher (DHR)", "summary": ""}, {"date": "20240418010000", "headline": "Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks", "summary": ""}, {"date": "20240418024600", "headline": "RBC Capital Reaffirms Their Buy Rating on Danaher (DHR)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240418031500", "headline": "Ensemble Fund Q1 2024 Investment Update", "summary": "Ensemble Fund's quarterly letter reviews the fund\u00e2\u0080\u0099s first quarter 2024 performance and highlight a couple portfolio companies. Click here to read more."}, {"date": "20240418034500", "headline": "DHR December 20th Options Begin Trading", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240418041800", "headline": "D.R. Horton Stock (NYSE:DHI): Build Your Portfolio from the Ground Up", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240418050600", "headline": "If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240418071521", "headline": "Curious about Danaher (DHR) Q1 Performance? Explore Wall Street Estimates for Key Metrics", "summary": "Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight."}, {"date": "20240418085800", "headline": "Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?", "summary": "Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives."}, {"date": "20240418101016", "headline": "Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?", "summary": "Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report."}, {"date": "20240418142703", "headline": "13 Best Low Volatility Stocks to Buy According to Hedge Funds", "summary": "In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds. To skip the detailed analysis of the current market conditions, go directly to the 5 Best Low Volatility Stocks to Buy According to Hedge Funds. The S&P 500 had a remarkable year in 2023 and the first quarter [\u2026]"}, {"date": "20240419075200", "headline": "Why Danaher (DHR) Might Surprise This Earnings Season", "summary": "Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season."}, {"date": "20240420031000", "headline": "Ensemble Capital - IDEX Corp:\u00a0 A Mundane Company Ready To Fire On All Cylinders", "summary": "We think IDEX might be ready to fire on all cylinders. But what are some of the risks we face as shareholders of IEX? Find out."}, {"date": "20240420035305", "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of April 21", "summary": "Stay informed about the latest dividend activity with this weekly summary, including updates on dividend changes, ex-dividend dates, and pay dates of top..."}, {"date": "20240420060300", "headline": "THQ: Collecting A High Yield From Increased Medical Spending", "summary": "abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield and exposure to diverse healthcare subsectors, outperforming peers. Explore more here."}, {"date": "20240422060700", "headline": "Spotlight on Danaher: Analyzing the Surge in Options Activity", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422062700", "headline": "Notable companies reporting before tomorrow's open", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422065100", "headline": "Danaher Q1 2024 Earnings Preview", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422183500", "headline": "GLOBAL BRIEFING: Japan's business activity growth speeds up in April", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422194800", "headline": "Tuesday Sector Leaders: Healthcare, Technology & Communications", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422230300", "headline": "Danaher Non-GAAP EPS of $1.92 beats by $0.21, revenue of $5.8B beats by $180M", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422230400", "headline": "Danaher reports Q1 adjusted EPS $1.92, consensus $1.71", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422230600", "headline": "Danaher sees Q2 revenue down mid-single digits, consensus $5.73B", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422230700", "headline": "Danaher sees FY24 revenue down low-single digits, consensus $24.05B", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423000200", "headline": "Danaher gains as Q1 results exceed expectations", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423000200", "headline": "Earnings Scheduled For April 23, 2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423000809", "headline": "Danaher: Q1 Earnings Snapshot", "summary": "WASHINGTON \u2014 WASHINGTON \u2014 Danaher Corp. on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share. Earnings,..."}, {"date": "20240423004708", "headline": "Danaher Posts Fall in 1Q Earnings, Continues to Expects Lower Annual Sales", "summary": "By Robb M. Stewart Danaher continues to expect underlying sales will fall this year, though it said it had a good start to the year with improving order trends in its bioprocessing business...."}, {"date": "20240423005000", "headline": "TOP NEWS: Danaher sets guidance as first quarter revenue falls", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423014300", "headline": "Biggest stock movers today: DHR, IBRX, NVS, and more", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423020500", "headline": "Fly Intel: Pre-market Movers", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423024000", "headline": "Biggest stock movers today: GM, DHR, IBRX, NVS, and more", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423024200", "headline": "Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Neurocrine (NBIX) and Medtronic (MDT)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423025600", "headline": "Early notable gainers among liquid option names on April 23rd", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423025700", "headline": "Biggest stock movers today: SPOT, GM, DHR, IBRX, NVS, and more", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423033731", "headline": "Here\u2019s Why Cooper Investors Sold Danaher Corporation (DHR)", "summary": "Cooper Investors, an investment management firm, released its \u201cCooper Investors Global Equities Fund\u201d first quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 7.4% in the first quarter, compared to a 9.4% return for the benchmark MSCI ACWI. The market rally, which started in late October 2023, has [\u2026]"}, {"date": "20240423035400", "headline": "DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q1 2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423035500", "headline": "HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423040000", "headline": "Danaher Reports First Quarter 2024 Results", "summary": "Danaher Corporation (NYSE: DHR) (the \"Company\") today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted."}, {"date": "20240423043908", "headline": "Danaher Corporation (DHR) Q1 2024 Earnings Call Transcript", "summary": "Danaher Corporation (NYSE:NYSE:DHR) Q1 2024 Earnings Conference Call April 23, 2024 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair -..."}, {"date": "20240423043924", "headline": "Danaher Corporation 2024 Q1 - Results - Earnings Call Presentation", "summary": "The following slide deck was published by Danaher Corporation in conjunction with their 2024 Q1 earnings call."}, {"date": "20240423051004", "headline": "Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates", "summary": "Danaher (DHR) delivered earnings and revenue surprises of 11.63% and 2.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?"}, {"date": "20240423053152", "headline": "Danaher Corp (DHR) Q1 2024 Earnings: Mixed Results Amid Market Challenges", "summary": "Revenue Declines but Earnings Per Share Exceed Expectations"}, {"date": "20240423060700", "headline": "Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423063800", "headline": "Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423065957", "headline": "Stocks to Watch Tuesday: GM, Spotify, UPS, Tesla", "summary": "? **Tesla (TSLA**): Traders' focus is on the EV maker's earnings, due after the market close. Tesla stock edged up in premarket trading, after a rocky stretch that has seen it fall over 40% in 2024. \u2197\ufe0f **General Motors (GM)**: Shares of GM leapt roughly 5% premarket after the car company raised its annual profit outlook."}, {"date": "20240423073026", "headline": "Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates", "summary": "Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers."}, {"date": "20240423084400", "headline": "Danaher Stock Jumps After Earnings Beat. It Shrugs Off Falling Sales Outlook.", "summary": "The medical company reports first-quarter adjusted earnings of $1.92 a share, beating Wall Street estimates of $1.72."}, {"date": "20240423092900", "headline": "Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y", "summary": "While Danaher (DHR) surpasses first-quarter earnings and revenue estimates, its performance is hurt by a decrease in core sales in the Biotechnology segment."}, {"date": "20240423093316", "headline": "Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives", "summary": "PulteGroup received an added data boost, Danaher's markets are looking up, and JetBlue collapses, despite a not-as-bad-as-feared loss."}, {"date": "20240423201758", "headline": "Q1 2024 Danaher Corp Earnings Call", "summary": "Q1 2024 Danaher Corp Earnings Call"}, {"date": "20240423215100", "headline": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423222900", "headline": "Danaher price target raised by $10 at Barclays, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423230243", "headline": "Decoding Danaher Corp (DHR): A Strategic SWOT Insight", "summary": "Insightful Analysis of Danaher Corp's Financial Fortitude and Market Position"}, {"date": "20240423233300", "headline": "Danaher price target raised by $10 at Citi, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423234100", "headline": "Danaher price target raised by $12 at Baird, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423234700", "headline": "RBC Capital Sticks to Its Buy Rating for Danaher (DHR)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424002100", "headline": "Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424002300", "headline": "Danaher price target raised by $10 at TD Cowen, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424005000", "headline": "Tesla To $180? Here Are 10 Top Analyst Forecasts For Wednesday", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424010115", "headline": "Danaher Corp (DHR) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...", "summary": "Amidst a mixed financial landscape, Danaher reveals its strategic maneuvers and future outlook in the latest earnings call."}, {"date": "20240424022400", "headline": "Danaher price target raised by $12 at BofA, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424075255", "headline": "Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Call Transcript", "summary": "Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Call Transcript April 23, 2024 Danaher Corporation misses on earnings expectations. Reported EPS is $1.45 EPS, expectations were $1.72. Operator: Hello. My name is Todd, and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation\u2019s First Quarter 2024 [\u2026]"}, {"date": "20240424135100", "headline": "Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks", "summary": "Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Regeneron Pharmaceuticals, Inc. (REGN) and Palo Alto Networks, Inc. (PANW)."}, {"date": "20240424212144", "headline": "Value Vs. Growth? Danaher Says Why Not Both?", "summary": "Danaher has shown resilience and strength in its core businesses despite post-pandemic growth challenges. Read why DHR stock is a Buy."}, {"date": "20240424214000", "headline": "Danaher Corp. stock falls Thursday, underperforms market", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425044403", "headline": "Danaher First Quarter 2024 Earnings: Beats Expectations", "summary": "Danaher ( NYSE:DHR ) First Quarter 2024 Results Key Financial Results Revenue: US$5.80b (down 2.6% from 1Q 2023). Net..."}, {"date": "20240425064400", "headline": "The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power", "summary": "Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power are part of the Zacks top Analyst Blog."}, {"date": "20240425102900", "headline": "Honeywell (HON) Q1 Earnings Beat, Aerospace Sales Rise Y/Y", "summary": "Honeywell's (HON) first-quarter 2024 revenues increase approximately 3%, driven by strong momentum in the Aerospace Technologies segment."}, {"date": "20240425110108", "headline": "Danaher Q1: The Worst Time Has Already Passed", "summary": "Danaher Corporation stock has surged by 16% since our \"Strong Buy\" rating in June 2023, outperforming S&P 500. Read my earnings analysis of DHR stock here."}, {"date": "20240425170043", "headline": "Senior Vice President - General Counsel Brian Ellis Sells 4,000 Shares of Danaher Corp (DHR)", "summary": "Senior Vice President - General Counsel Brian Ellis has sold 4,000 shares of Danaher Corp (NYSE:DHR) on April 24, 2024, according to a recent SEC Filing."}, {"date": "20240425190700", "headline": "Buy Rating on Danaher: Strong Biotech Performance and Growth Potential Despite Market Challenges", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240426130922", "headline": "ABT, DHR, DXCM: Which \u201cStrong Buy\u201d Healthcare Stock Has More Upside?", "summary": "The healthcare scene is home to some pretty defensive companies that aren\u2019t exactly shying away from medical innovation. With the following Strong-Buy-rated health stocks (ABT, DHR, and DXCM), investors may just be able to get growth, relative defensiveness, and decent multiples as we head into May 2024. Undoubtedly, investors may wish to come for the underestimated growth and stay for their ability to move higher, even as the market tides turn against most stocks in the market. Therefore, in th"}, {"date": "20240427060800", "headline": "Danaher Corporation: A Good Medium Term Bet", "summary": "Danaher Corporation's sales growth is projected to improve, along with margins, while valuation appears reasonable on future earnings estimates. Explore more here."}, {"date": "20240428201100", "headline": "Fly Insider: Zura Bio, Google among week's notable insider trades", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240429041300", "headline": "See Which Of The Latest 13F Filers Holds Danaher", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240429083920", "headline": "Fortive Corporation: Growing Into The Valuation", "summary": "Fortive Corporation is a well-positioned conglomerate with high-quality, high-growth businesses in intelligent operating solutions. Explore more details here."}, {"date": "20240429220100", "headline": "Analysts Think This 170% Dividend Grower Is \u201cOld News.\u201d They\u2019re Wrong.", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501000100", "headline": "Danaher Corp: An Exploration into Its Intrinsic Value", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501034500", "headline": "Danaher call volume above normal and directionally bullish", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501041704", "headline": "Increases to Danaher Corporation's (NYSE:DHR) CEO Compensation Might Cool off for now", "summary": "Key Insights Danaher to hold its Annual General Meeting on 7th of May CEO Rainer Blair's total compensation includes..."}, {"date": "20240502024700", "headline": "B&G Foods (BGS) Gets a Hold from RBC Capital", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240502213900", "headline": "Danaher Moves Up In Market Cap Rank, Passing Abbott Laboratories", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240503030708", "headline": "Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE\u2122 Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry", "summary": "WOBURN, Mass., May 3, 2024 /PRNewswire/ -- Curiox\u00a0Biosystems\u00a0Co.\u00a0Ltd\u00a0, a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in..."}, {"date": "20240503054721", "headline": "Danaher : To treat Alzheimer\u2019s, first we must diagnose it", "summary": "There's one image around Alzheimer's that comes into my mind almost daily. At Alzheimer's Association walks, participants each carry a flower whose color reflects their relationship with the..."}, {"date": "20240503070600", "headline": "Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE\u2122 Technology with DURA  Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry", "summary": "Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for \ufb02ow cytometry."}, {"date": "20240503114800", "headline": "Markel (MKL) Q1 Earnings, Revenues Miss Estimates, Rise Y/Y", "summary": "Markel (MKL) first-quarter results reflect improved earned premiums and increased net investment income."}]}